| Literature DB >> 33235140 |
Richard T Graham1, Erica H Bell2, Amy Webb3, Yue Zhao3, Cynthia Timmers4, Jessica L Fleming2, Blake E Sells2, Nathan J Robison5, Joshua D Palmer2, Jonathan L Finlay6, Arnab Chakravarti2.
Abstract
Gliosarcoma is rare among pediatric patients and among individuals with Neurofibromatosis Type 1 (NF1). Here we compare 2 pediatric gliosarcoma patients, one of whom has NF1. We performed whole-exome sequencing, methylation, and copy number analysis on tumor and blood for both patients. Whole-exome sequencing showed higher mutational burden in the tumor of the patient without NF1. Copy number analysis showed differences in chromosomal losses/gains between the tumors. Neither tumor showed O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation. The NF1 patient survived without progression while the other expired. This is the first reported case of gliosarcoma in a child with NF1.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33235140 DOI: 10.1097/MPH.0000000000002020
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289